Oncology Reports · 2006 · 20 citations · 14 references
Life SciencesImmunologyOncologyCancer ImmunologyTumor ImmunologyVirologyCancer ImmunotherapyCytokines In Tumor ImmunityOncogenic VirusesTumor Microenvironment ModulationCellular Immune Response To VirusesOncolytic Viral VectorsVaccinia Virus VectorsViral Expression Vectors
The enhanced Semliki Forest virus vector (SFV10-E), an RNA-based suicide expression vector system, expresses foreign genes at levels up to 10x higher than the original SFV10 vector. This vector has been used previously to express interleukin-12 for a tumour treatment study in a BALB/c murine model. Interleukin-18, an IFN-gamma-inducing cytokine, plays a key role in the early induction of T helper1 (Th1) cell-mediated immune responses in addition to anti-angiogenic activity. In this study, the murine IL-18 gene along with an Ig-kappa leader sequence was cloned into the SFV10-E vector. The pSFV10-E-IL-18 construct was characterised in vitro for levels of expression and secretion, and the production of biologically active IL-18 was confirmed. An in vivo tumour treatment study using high titre rSFV10-E-IL-18 virus-like particles to treat subcutaneous K-BALB and CT26 tumours in BALB/c mice demonstrated therapeutic efficacy including the disappearance of tumour cells in a minority of treated animals. Tumour regression was associated with induction of avascular and suppurative necrosis.
14
Establishment of mouse colonic carcinoma cell lines with different metastatic properties.
Michael G. Brattain, Janna D. Strobel‐Stevens, David Fine et al. · PubMed · 1980 · 234 citations
Medicine, Cell Biology, Oncology +17